Our providers have experience with a variety of injectable, oral, and infusion treatments for MS and in treating a variety of neuroimmunological conditions. They will work with you to find a therapy that meets your needs based on your symptoms and personal preferences.
Our clinic regularly participates in clinical trials to evaluate new treatments and treatment regimens for MS and other neuroimmunological conditions, including cyclosporine, beta-seron, avonex/rebif, and steroids for optic neuritis. Finally, we are an integral part of the Duke Center for Research in Autoimmunity and Multiple Sclerosis (DREAMS), a multidisciplinary group of basic and clinical researchers dedicated to improving our understanding of, and patient care for, MS and autoimmune diseases.
Nathan “Troy” Tagg, MD, has been fascinated in both vision and the brain and nervous system since his first year of medical school. Now, he’s following both of those passions as a neuro-ophthalmologist and neuro-immunologist at Duke. For this week’s “Faculty Spotlight” interview, Tagg talks to us about an early learning module that cemented his interests, the joys of helping patients with their vision, and enjoying outdoor time with family when he’s not at Duke.
As a medical student, Paige Sutton, MD, received the following advice: choose a specialty where you won’t constantly check your watch waiting for the day to end. Sutton chose neurology and neuroimmunology in particular and has never looked back. For this week’s Spotlight interview, our current multiple sclerosis (MS) and neuroimmunology fellow talks about her time as a fellow so far, working with patients to make decisions that are best for their lifestyles and preferences, and enjoying hiking, playing the guitar and exploring North Carolina when she’s not at Duke.
Since childhood, Nidhila Masha has been fascinated by the human brain as a “final frontier” still open for additional discoveries and study despite the advances of modern science. Now, as a third-year medical student at the Duke University School of Medicine, she’s exploring that frontier--and upending conventional wisdom--with a research project examining therapies for multiple sclerosis (MS) during the COVID-19 pandemic. For this week’s Spotlight interview, Masha talks to us about how her research will help patients with MS make more informed decisions about their therapy choices.
The first month of 2022 saw the publication of 18 new peer-reviewed journal articles from members of the Duke Neurology Department. Highlights include a new article in Lancet Neurology discussing the epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders, case reports describing the progression and treatment options for rare neurological conditions, and a summary of how the first year of the COVID-19 pandemic affects neurology residency programs in the United States.
The Duke Neurology Department continued to grow and expand its missions of providing excellent clinical care, conducting research to improve our understanding of neurological conditions and how to treat them, and training the next generation of neurologists throughout 2021.
Members of the Duke Neurology Department contributed to seventeen peer-reviewed research studies published this August. Members of the lab of Nicole Calakos, MD, PhD, discovered that a medication created to treat patients with HIV may help people with dystonia. New translational research provided the most accurate atlas of the mouse model to date and answered questions about late-onset Alzheimer’s disease.
Members of the Duke Neurology Department did their part for Stroke Awareness Month, contributing to eight new peer-reviewed studies published this May. But our other divisions didn’t hold back either, with thirteen other articles advancing our understanding of neuro-oncology, multiple sclerosis, headache, and other subjects.
Read about each of the studies published from members of the Duke Neurology Department below, and find links to the original journal articles as well.
The American Academy of Neurology (AAN) has moved its annual meeting to a virtual setting this year, but its offerings of the latest education and scientific programming continue. This year, members of the Duke Neurology Department collaborated with their colleagues at Duke and with other academic institutions to advance our understanding of neuro-oncology, myasthenia gravis, ALS, and other fields and disciplines.
Members of the Duke Neurology Department contributed to 21 new studies in peer-reviewed journals this March, advancing our ability to understand, treat, and prevent diseases and conditions from across the field of neurology. Brian Mac Grory, MB BCh, MRCP, and other members of our stroke and vascular neurology helped answer questions about the best way to treat patients who have a stroke in their sleep.
Gender has numerous effects across all fields of health, including neurology. For Women's History Month 2021, providers from the Duke Departments of Neurology and Neurosurgery discussed how conditions like multiple sclerosis, epilepsy, and spinal injuries intersect with women's health. In this week's entry, Suma Shah, MD discusses multiple sclerosis, which is twice as common in women as it is in men.